Peter Soltani Net Worth

The estimated Net Worth of Peter Soltani is at least $6.73 Million dollars as of 27 February 2013. Peter Soltani owns over 88,729 units of Hologic stock worth over $6,137,087 and over the last 21 years Peter sold HOLX stock worth over $596,831.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Peter Soltani HOLX stock SEC Form 4 insiders trading

Peter has made over 8 trades of the Hologic stock since 2004, according to the Form 4 filled with the SEC. Most recently Peter exercised 88,729 units of HOLX stock worth $1,294,556 on 27 February 2013.

The largest trade Peter's ever made was exercising 88,729 units of Hologic stock on 27 February 2013 worth over $1,294,556. On average, Peter trades about 6,718 units every 138 days since 2004. As of 27 February 2013 Peter still owns at least 76,704 units of Hologic stock.

You can see the complete history of Peter Soltani stock trades at the bottom of the page.

What's Peter Soltani's mailing address?

Peter's mailing address filed with the SEC is 35 CROSBY DRIVE, , BEDFORD, MA, 01730.

Insiders trading at Hologic

Over the last 30 years, insiders at Hologic have traded over $311,276,394 worth of Hologic stock and bought 385,967 units worth $8,452,795 . The most active insiders traders include Carl Chigh River Limited Pa..., Carl C Icahn, and Stephen P Macmillan. On average, Hologic executives and independent directors trade stock every 22 days with the average trade being worth of $3,042,940. The most recent stock trade was executed by Karleen Marie Oberton on 29 August 2024, trading 52,679 units of HOLX stock currently worth $4,243,820.

What does Hologic do?

driven by our ethos, the science of sure, we’re a diverse, dedicated, creative team that develops, markets and services some of the most innovative and accurate diagnostic imaging systems and surgical products on the planet. while we’re focused and passionate about our work, we never forget that what we’re really doing is giving people greater confidence and peace of mind in their diagnosis—enabling healthier lives, everywhere, every day. connect with us at hologic.com, on facebook at facebook.com/hologicjobs, and on twitter @hologic_jobs.

Complete history of Peter Soltani stock trades at Hologic

Hologic executives and stock owners

Hologic executives and other stock owners filed with the SEC include:

• Stephen MacMillan,
  Chairman of the Board, President, Chief Executive Officer
• Stephen P. MacMillan,
  Chairman, CEO & Pres
• Kevin Thornal,
  Division President, Diagnostics
• John Griffin,
  General Counsel
• Peter Valenti,
  Division President - Breast and Skeletal Health
• Karleen Oberton,
  Chief Financial Officer
• Kevin R. Thornal,
  Division Pres of Diagnostic Solutions
• John M. Griffin,
  Gen. Counsel
• Sean S. Daugherty,
  Group Pres of Breast/Skeletal Health & GYN Surgical Solutions
• Sally Crawford,
  Lead Independent Director
• Ludwig Hantson,
  Independent Director
• Charles Dockendorff,
  Independent Director
• Scott Garrett,
  Independent Director
• Namal Nawana,
  Independent Director
• Amy Wendell,
  Independent Director
• Christiana Stamoulis,
  Independent Director
• Michael Watts,
  Vice President - Investor Relations and Corporate Communications
• Allison Bebo,
  Senior Vice President - Human Resources
• Mike Kelly,
  Chief Supply Chain Officer and Corp. VP of Quality Assurance & Regulatory Affairs
• Paul Malenchini,
  Chief Information Officer
• Elisabeth A. Hellmann,
  Sr. VP of Global HR & Corp. Communications
• Ryan Simon,
  VP of Investor Relations
• Monica Aguirre Berthelot,
  Chief of Staff
• Sanjay Prabhakaran,
  Regional Pres of Asia Pacific
• Jan Verstreken,
  Group Pres of International
• Dr. Jay A. Stein,
  Co-Founder, Chairman Emeritus, CTO & Sr. VP
• Elaine Ullian,
  Director
• Nancy Leaming,
  Director
• Thomas A. West,
  Div President & GM, Diagnostic
• Christopher J Coughlin,
  Director
• Eric B. Compton,
  COO
• Robert W. Mc Mahon,
  Chief Financial Officer
• Lawrence M Levy,
  Director
• Carl Hull,
  SVP and GM of Diagnostics
• Peter Soltani,
  Vice President
• Benjamin Jordan Cohn,
  Principal Accounting Officer
• Steven S. Williamson,
  SVP, GYN Surgical
• John R Pekarsky,
  Sr. VP, Sales
• Howard Jr Doran,
  Vice President & BUD, ThinPrep
• Arthur G Lerner,
  Director
• Laurie Fajardo,
  Director
• Robert Cascella,
  President & COO
• William A Peck,
  Director
• Stuart A Kingsley,
  President, Surgical Division
• Irwin Jacobs,
  Director
• C William Mcdaniel,
  Director
• Stetten Eric Von,
  Vice President
• Daniel J Levangie,
  Director
• Patrick J Sullivan,
  Director
• Wayne Wilson,
  Director
• Jay A Stein,
  Director
• Samuel J. Merksamer,
  Director
• Jonathan Christodoro,
  Director
• David R Jr Lavance,
  Director
• Claus Egstrand,
  SVP and GM, International
• Carl Chigh River Limited Pa...,
  
• Rohan Hastie,
  Group VP & GM, Diagnostics
• Roger D. Mills,
  SVP & GM, Service & Operations
• Robert H Lavallee,
  Vice President
• Mark J Casey,
  Senior V.P & General Counsel
• Carl C Icahn,
  10% owner
• David Harding,
  SVP, International
• David J Brady,
  SVP, Human Resources
• Glenn P Muir,
  Executive VP & CFO
• John W Cumming,
  Chairman & CEO
• Sean S. Daugherty,
  Group President, BSH & Surg.
• Jan Verstreken,
  Group President, International
• Nanaz Mohtashami,
  Director
• Brandon Schnittker,
  Div. President, GYN Surgical
• Elisabeth A Hellmann,
  SVP, Human Resources
• Erik S Anderson,
  Div. Pres., Breast & Skeletal
• Essex D Mitchell,
  Div. President, GYN Surgical
• Stacey D. Stewart,
  Director
• Jennifer M Schneiders,
  President, Diag. Solutions
• Peter Paul Dunne,
  SVP, Human Resources